Illumina Reports 163 Percent Jump in Q2 Sales; Raises Full-Year Guidance | GenomeWeb
NEW YORK (GenomeWeb News) - Illumina yesterday reported a 163-percent surge in second-quarter revenues and swung into profitability from a loss in the second quarter of 2005.
Total receipts for the three months ended July 2 increased to $41.6 million from $15.8 million in the same quarter one year ago.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.